A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of Guillain-Barré syndrome (GBS) following vaccination. To assess the risk of GBS with these ...

Health officials have estimated about two cases of Guillain-Barre syndrome in every 1 million people who receive the RSV vaccine within three weeks of getting the shot. The new CDC report focused ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination ...

We present a case of Guillain-Barré syndrome in a child who received hepatitis A vaccine 5 days before onset of the clinical symptoms. In our patient, the association of Guillain-Barré syndrome ...

India's western city of Pune is battling rising cases of the Guillain-Barré Syndrome (GBS), with at ... This is because vaccines tend to have similar weak or inactive structures akin to the ...

A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barre syndrome (GBS), has been identified.

So far, 59 people in Pune have been diagnosed with Guillain-Barré Syndrome (GBS), a rare neurological ... the disorder is linked to the COVID-19 vaccine. In response, The Free Press Journal ...